Soleno Therapeutics Files 8-K
Ticker: SLNO · Form: 8-K · Filed: Aug 6, 2025 · CIK: 1484565
| Field | Detail |
|---|---|
| Company | Soleno Therapeutics Inc (SLNO) |
| Form Type | 8-K |
| Filed Date | Aug 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K, financial-reporting
Related Tickers: SLNO
TL;DR
SOLENO THERAPEUTICS (SLNO) filed an 8-K on 8/6/25, confirming fiscal year end and corporate details.
AI Summary
On August 6, 2025, Soleno Therapeutics, Inc. filed an 8-K report. The filing indicates the company's fiscal year ends on December 31st. Soleno Therapeutics, formerly Capnia, Inc., is incorporated in Delaware and its principal executive offices are located in Redwood City, California.
Why It Matters
This 8-K filing provides standard corporate information and updates regarding Soleno Therapeutics, Inc.'s operational and financial reporting status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K with standard corporate information and does not appear to contain material non-public information that would immediately impact stock price.
Key Numbers
- 001-36593 — SEC File Number (Identifies the company's filing with the SEC.)
- 77-0523891 — IRS Employer Identification Number (Company's tax identification number.)
Key Players & Entities
- SOLENO THERAPEUTICS, INC. (company) — Registrant
- Capnia, Inc. (company) — Former company name
- August 6, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Redwood City, CA (location) — Principal executive offices
- 1231 (date) — Fiscal year end
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting standard corporate information and the date of the earliest event reported.
When was the report filed and what is the earliest event date?
The report was filed on August 6, 2025, and the earliest event reported is also August 6, 2025.
What is Soleno Therapeutics, Inc.'s fiscal year end?
Soleno Therapeutics, Inc.'s fiscal year ends on December 31st.
What was Soleno Therapeutics, Inc. formerly known as?
Soleno Therapeutics, Inc. was formerly known as Capnia, Inc.
Where are Soleno Therapeutics, Inc.'s principal executive offices located?
Soleno Therapeutics, Inc.'s principal executive offices are located at 100 Marine Parkway, Suite 400, Redwood City, CA 94065.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 6, 2025 regarding SOLENO THERAPEUTICS INC (SLNO).